SOMATOSTATIN AND VASOACTIVE-INTESTINAL-PEPTIDE REDUCE INTERFERON GAMMA PRODUCTION BY HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS

被引:86
作者
MUSCETTOLA, M [1 ]
GRASSO, G [1 ]
机构
[1] UNIV SIENA, INST HUMAN ANAT, I-53100 SIENA, ITALY
关键词
Eagle's Minimum Essential Medium; EMEM; human amnionic cells; IFN-γ; IL; 2; interferon gamma; interleukin-2; large granular lymphocytes; LGL; PBMC; PBS; peripheral blood mononuclear cells; PFU; phosphate-buffered saline; plaque-forming units; SEA; SOM; somatostatin; staphylococcal enterotoxin A; vasoactive intestinal peptide; vesicular stomatitis virus; VIP; VSV; WISH;
D O I
10.1016/S0171-2985(11)80303-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
There is increasing evidence that neuropeptide modulation of the immune response is an important physiological phenomenon which involves the interaction of peptidergic neuromodulators with specific neuropeptide receptors on the plasma membrane of immune effector cells. Many studies have examined the effect of neuropeptides on mitogen-induced lymphocyte proliferation and immunoglobulin synthesis but very little is known about specific lymphokine production. In this study, we describe the effect of somatostatin (SOM) and vasoactive intestinal peptide (VIP) on interferon gamma (IFN-γ) production by normal human peripheral blood mononuclear cells (PBMC) stimulated in vitro with polyclonal T cell activator staphylococcal enterotoxin A (SEA). Our findings provide experimental evidence that both SOM and VIP reduce the IFN-γ production by SEA-stimulated PBMC. This reduction was time- (with maximal effect at 72h) and dose-dependent (at doses as low as 10-11 M with maximal effect at concentrations between 10-9 and 10-8 M of neuropeptides). This effect was absent in resting PBMC. The meaning of inhibitory effect of VIP and SOM on IFNγ production and its role in immune response in vivo are discussed. © 1990, Gustav Fischer Verlag · Stuttgart · New York. All rights reserved.
引用
收藏
页码:419 / 430
页数:12
相关论文
共 50 条
  • [1] ADER R, 1987, Brain Behavior and Immunity, V1, P1, DOI 10.1016/0889-1591(87)90001-8
  • [2] BESEDOVSKY HO, 1985, J IMMUNOL, V135, pS750
  • [3] IDENTIFICATION OF HUMAN MONONUCLEAR LEUKOCYTES BEARING RECEPTORS FOR SOMATOSTATIN AND GLUCAGON
    BHATHENA, SJ
    LOUIE, J
    SCHECHTER, GP
    REDMAN, RS
    WAHL, L
    RECANT, L
    [J]. DIABETES, 1981, 30 (02) : 127 - 131
  • [4] INTERFERON-PRODUCTION BY MITOGEN-STIMULATED HUMAN-LYMPHOCYTES REQUIRES DIFFERENTIATION BUT NOT DNA-SYNTHESIS
    BHAYANI, HR
    WILLIAMS, GT
    JOHNSTONE, AP
    [J]. HUMAN IMMUNOLOGY, 1985, 13 (03) : 151 - 160
  • [5] BLALOCK JE, 1985, J IMMUNOL, V135, pS858
  • [6] BOISSARD C, 1986, CANCER RES, V46, P4406
  • [7] BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
  • [8] CARLSSON R, 1988, J IMMUNOL, V140, P2484
  • [9] DANEK A, 1983, J IMMUNOL, V131, P1173
  • [10] DELREY A, 1987, HORMONES IMMUNITY, P215